Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 15/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12328551 | 1.00 | FAAH (0.49) | FAAHKDM4EALDH1A1ENPP2 | |
| SCHEMBL19492816 | 0.81 | ENPP2 (0.48) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL488570 | 0.81 | KDM4E (0.51) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL2557935 | 0.80 | ADRA2C (0.59) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL29554265 | 0.80 | ADRA2C (0.59) | KDM4EALDH1A1ENPP2 | |
| Hydrochloric Acid SCHEMBL29957597 | 0.80 | KDM4E (0.50) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL12266120 | 0.80 | MGLL (0.50) | KDM4EALDH1A1ENPP2 | |
| Hydrochloric Acid SCHEMBL2379090 | 0.80 | KDM4E (0.50) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL1529259 | 0.80 | ALDH1A1 (0.50) | KDM4EALDH1A1ENPP2 | |
| SCHEMBL28700775 | 0.80 | KDM4E (0.59) | FAAHKDM4EALDH1A1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250032454-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | IMAGO BIOSCIENCES, INC. (US) | 2025-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250032454-A1 | KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE | KDM1B, KDM1A, KDM2A | FAAH 4319/4885KDM4E 20/4885ALDH1A1 734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.